Pioneering Paths: Women Leadership in Rare Disease
May 15, 2024 | Women in healthcare, daretothinkrare, rare disease
Rare diseases are often thought of as affecting one in 100,000 or one in 1,000,000 people, and that is true for some conditions. But there are many rare diseases that are more common. It may surprise many to learn that a condition that’s considered rare has a prevalence of 1 in 2000 or lower, and rare diseases overall affect more than 300 million people worldwide.
When a rare genetic condition runs in your family, when you see the impact it has, and you grow up alongside a rare disease patient advocacy group started by your parents, you gain quite a lot of lived experience, says Lucy McKay, MD. “There was so much that I learned and saw.”
As McKay made her way through medical school she was disheartened to find that medicine and the NHS [National Health Service] were not receptive to her experience and accumulated knowledge. They didn’t recognize the common challenges in rare disease, they did not include rare disease patients in medical studies, and they weren’t preparing future clinicians to support rare disease patients and their families. “It was impossible for me to stay working in that environment,” McKay says. “I could not do the career I chose.”
So what to do? If you are McKay, you grab your medical degree and start the UK-based charity Medics4RareDiseases (and also become a steering committee member of Medscape Education’s rare disease initiative).
In fact, she says, it’s not surprising that most rare disease advocacy leaders are women. “Approximately 70 to 75 percent of rare conditions present solely in childhood, and a similar proportion are genetic conditions. The caregivers are more likely to be female, see the signs earlier, and be living that experience with their child as their needs become more obviously understood.
“When women get activated, what do they get activated by? In rare disease, it’s because these needs are wholly unmet,” says McKay. “There’s no one out there coordinating this drive to help their children or to help their other loved ones.” So women step in and start making a lot of noise because they have no choice.
Abigail Epstein, head of communications and patient advocacy for Takeda UK and Ireland, may not have grown up in a family of advocates, but she is no less passionate about helping to improve the lives of everyone affected by a rare condition in a world that really doesn’t understand their needs. “I’ve taken inspiration from the community, which has this incredible ability to work together for the betterment of one another and what needs to be done—against incredibly difficult odds.
Epstein works on a campaign called I am number 17, to raise awareness of the fact that one in 17 people are affected by a rare disease at some point in their lifetime. Worldwide, rare diseases affect roughly 263 to 446 million people. That statistic, Epstein says, originated from Genetic Alliance but was not well recognized outside the rare community. “As a group,” she says, “we wanted to change that. Because though individually rare, rare conditions are collectively common.”
And things are starting to change, she says. That one in 17 statistic is now a common part of discourse when rare diseases are looked at. And now more than ever, pharmaceutical companies have a lot in the pipeline for rare diseases.
The pharmaceutical industry is also leading the way when it comes to employing and supporting women. Though women are the driving force for change in rare disease, McKay and Epstein both acknowledge that the leap from kitchen table charity work to chairing a disease conference can be a hurdle. “When you start looking at organizations that work in rare that are profit-making or anyone who’s in a decision-making role, suddenly the room starts to become more male,” McKay says. “Even though this industry was built on female advocacy.”
A 2021 workplace study from the Association of the British Pharmaceutical Industry “found that women make up more than 54% of the pharma workforce in England,” Epstein says. “At Takeda, I’m proud of the fact that 56% of the general managers across Europe and Canada are women. It’s really important to continue that momentum, encouraging women to pursue careers in science and technology, whether that be through mentorships or other opportunities, making a conscious effort to promote women into leadership.”
Hosted by Christy Rohani-Montez, PhD, Director of Clinical Strategy at Medscape Education Global
Follow us on LinkedIn for updates on upcoming podcasts and more insightful conversations.
For more information, please contact Jelena Spyropoulos (Global) or Piyali Shin (US).
To learn more about rare diseases, visit Medscape’s Pathways in Rare Disease, https://www.medscape.org/sites/advances/rare-diseases, Medics for Rare Diseases, m4rd.org, or I am Number Seventeen at iamnumber17.org.uk
About Medscape Education Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free accredited CME and CE courses for physicians, nurses, and other healthcare professionals.
This content was provided by Medscape Education Global
Company Details
Latest Content from Medscape Education Global
Medscape’s Rare Disease Learning Center Has Reached 1 Million Learners
The Pathways in Rare Disease Learning Center celebrates a momentous achievement - engaging one million learners in its educational initiatives. This milestone signifies a profound impact on clinician confidence in...
Continuing Medical Education Outcomes are Much More Than Statistical Significance
At Medscape Education, we hold ourselves to the highest standards when it comes to analysing our programs. Our approach is unparalleled, employing a precise paired method that ensures we measure the...
The Most Important Person in the Room—A Look at Patient -Centricity at EHA
Across all of healthcare, a greater focus is being placed on patient centricity in order to improve outcomes and enhance patients’ quality of life. Although patient centricity is necessary in...
Innovation in Education Leads to Positive Outcomes at EAN 2023
The Medscape team recently returned from the 9th Annual Congress of the European Academy of Neurology (EAN) in Budapest, Hungary. Among the various highlights of the congress, the team showcased...
The Lasting Impact of Cytomegalovirus Education
Education on the signs, symptoms, and potential complications of cytomegalovirus (CMV) is in need of constant development, as this common disease affects nearly 1 in 3 children by age 5...
Medscape Education Publishes the Results of Multinational, Multispecialty Survey of Physicians on Rare Disease Educational Needs
Medscape Education has published the results of a global survey of its kind, assessing the educational needs of physicians on rare diseases. This survey of 978 clinicians worldwide across 16...
Medscape Showcases Outcomes in Austria for EASL Congress
Medscape recently attended the EASL Congress in Austria, where they successfully showcased the outcomes of their Wilson Disease education program. One of their achievements was presenting a poster on "Online...
Medscape is Bringing Outcomes to the #HomeOfNeurology
Budapest, Hungary is set to become Medscape's next destination as they gear up for the highly anticipated 9th Annual Congress of the European Academy of Neurology. As an integral part...
Medscape Education: ACOG 2023 Publication
Medscape Education is making a difference! We are wrapping CMV Awareness Month with a look at the impact of CMV education on OB/GYN learners. Take a look as Medscape Senior...
It’s the Era of Outcomes at ERA 2023
The Medscape team has bid farewell to the beautiful city of Milano, Italy and our European nephrology colleagues. The team was thrilled to meet up with so many ground-breaking clinicians,...